Related Experiment Video
Updated: Mar 23, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
[Smoking, smoking cessation and Crohn's disease]
Michel Underner1, Jean Perriot2, Jacques Cosnes3
1CHU La Milétrie, pavillon René-Beauchant, service de pneumologie, unité de tabacologie, BP 577, 86021 Poitiers cedex, France.
Smoking significantly worsens Crohn's disease (CD) outcomes, increasing complications and the need for surgery. Quitting smoking is crucial for managing CD and improving patient health.
Area of Science:
- Gastroenterology and Internal Medicine
- Public Health and Epidemiology
Background:
- Smoking is more prevalent in Crohn's disease (CD) patients and exacerbates the condition.
- Conversely, ulcerative colitis predominantly affects non-smokers, with smoking potentially improving disease course.
Purpose of the Study:
- To systematically review the relationship between smoking, smoking cessation, and Crohn's disease.
- To synthesize current data on the impact of smoking on CD progression and management.
Main Methods:
- A systematic literature review was conducted using Medline (1980-2015).
- Keywords included 'Crohn's disease' or 'inflammatory bowel disease' and 'smoking' or 'smoking cessation'.
- 168 abstracts were dual-read, selecting 69 studies (case-control, retrospective, reviews, meta-analysis).
Main Results:
- Smoking increases the risk of CD complications, disease recurrence, and the need for surgery, corticosteroids, or immunosuppressants.
- These negative effects of smoking are more pronounced in women.
- Smoking cessation demonstrably improves disease course and is a vital management strategy.
Conclusions:
- Smokers with CD require consistent counseling on the detrimental effects of smoking and the benefits of cessation.
- Assistance in quitting smoking should be an integral part of Crohn's disease management.
- Study heterogeneity was noted regarding study types, population characteristics, smoking status definitions, and cessation validation.
More Related Videos
09:25Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD